SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-06-247791
Filing Date
2006-12-06
Accepted
2006-12-06 16:35:08
Documents
11
Period of Report
2006-11-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 19209
2 AMENDED AND RESTATED LEASE AGREEMENT dex101.htm EX-10.1 246740
3 AMENDED AND RESTATED LEASE AGREEMENT dex102.htm EX-10.2 242630
4 PRESS RELEASE dex991.htm EX-99.1 10563
5 GRAPHIC g43973ima003.jpg GRAPHIC 144126
6 GRAPHIC g43973img001.jpg GRAPHIC 289828
7 GRAPHIC g43973img002.jpg GRAPHIC 110938
8 GRAPHIC g43973img004.jpg GRAPHIC 112971
9 GRAPHIC g43973img005.jpg GRAPHIC 123226
10 GRAPHIC g43973img007.jpg GRAPHIC 3311
11 GRAPHIC g43973img06.jpg GRAPHIC 16298
  Complete submission text file 0001193125-06-247791.txt   1624899
Mailing Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466
Business Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466 9199419777
INSPIRE PHARMACEUTICALS INC (Filer) CIK: 0001040416 (see all company filings)

IRS No.: 043209022 | State of Incorp.: DE
Type: 8-K | Act: 34 | File No.: 001-31577 | Film No.: 061260422
SIC: 2834 Pharmaceutical Preparations